Effective Combination Therapy with Nizatidine and Acotiamide for Functional Dyspepsia

Effective Combination Therapy with Nizatidine and Acotiamide for Functional Dyspepsia - Effective Combination Therapy with Nizatidine and Acotiamide for Functional Dyspepsia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056721

Enrollment

Registered

2025-01-15

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with functional dyspepsia from Japan who received combination therapy with nizatidine and acotiamide or rabeprazole and acotiamide in Fuyoukai Murakami Hospital from October 1, 2014 to September 30, 2024

Exclusion criteria

Exclusion criteria: Patients wiht unknown outcome or Helicobacter pylori infection

Design outcomes

Primary

Measure	Time frame
Symptom improvement rates following treatment	—

Countries

Japan

Contacts

Public ContactYusaku Kajihara

Fuyoukai Murakami Hospital Department of Gastroenterology

y_kaji2012@yahoo.co.jp+81-17-729-8888

Outcome results